Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakshmi Rajdev

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline UpdateManish A Shah, Erin B Kennedy, Dana Deighton, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2024
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO GuidelineVan K Morris, Erin B Kennedy, Manik A Amin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 StudyThomas A Rasmussen, Lakshmi Rajdev, Ajantha Rhodes, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
The Lancet. Oncology|January 17, 2022
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trialHoward P Safran, Kathryn Winter, David H Ilson, et al.
Cancer Research Communications|February 16, 2024
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V T Catenacci, Melissa R Junttila, Theodore Karrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO GuidelineManish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline UpdateManish A Shah, Erin B Kennedy, Dana Deighton, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2024
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO GuidelineVan K Morris, Erin B Kennedy, Manik A Amin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 StudyThomas A Rasmussen, Lakshmi Rajdev, Ajantha Rhodes, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
The Lancet. Oncology|January 17, 2022
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trialHoward P Safran, Kathryn Winter, David H Ilson, et al.
Cancer Research Communications|February 16, 2024
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V T Catenacci, Melissa R Junttila, Theodore Karrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO GuidelineManish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Pageof 5